To assess the therapeutic effect of NCoR1 deletion in IECs on obesity and metabolic syndrome after disease onset, we generated inducible NCoR1-knockout mice (NCoR1ΔIECi mice) utilizing vil-Cre-ERT2 mice.36 This evidence concerns the gene MAPK3 and metabolic syndrome.